ERNEST HAWK

TitleProfessor
InstitutionMD Anderson
DepartmentClinical Cancer Prevention
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Torres HA, Mustafayev K, Juneau RP, Hwang JP, Wang LS, Angelidakis G, Hawk E, Granwehr BP, Yepez Guevara E, Ying AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. J Natl Compr Canc Netw. 2024 May 10; 22(2D). PMID: 38729204.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    2. Schrank BR, Fuller JA, Gallagher CM, Morris VK, Holliday EB, Merriman K, Nguyen L, Weaver L, Nelson K, Chiao E, Koong AC, Hawk E, Chang S. Institution-Wide Retreats Foster Organizational Learning and Action at a Comprehensive Cancer Center. J Cancer Educ. 2024 Aug; 39(4):368-373. PMID: 38468110; PMCID: PMC11219397.
      Citations:    Fields:    Translation:Humans
    3. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI, Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 Jul 01; 80(1):87-101. PMID: 38381705; PMCID: PMC11191046.
      Citations:    Fields:    Translation:Humans
    4. Oestman K, Rechis R, Williams PA, Brown JA, Treiman K, Zulkiewicz B, Walsh MT, Basen-Engquist K, Rodriguez T, Chennisi C, Macneish A, Neff A, Pomeroy M, Bhojani FA, Hawk E. Reducing risk for chronic disease: evaluation of a collective community approach to sustainable evidence-based health programming. BMC Public Health. 2024 01 20; 24(1):240. PMID: 38245669; PMCID: PMC10799505.
      Citations:    Fields:    Translation:Humans
    5. Hawk ET, Martch SL. Recent American College of Physicians Guidance Statement for Screening Average-risk, Asymptomatic Adults for Colorectal Cancer. Cancer Prev Res (Phila). 2024 01 04; 17(1):1-5. PMID: 38173395.
      Citations:    Fields:    Translation:Humans
    6. Rechis R, Oestman KB, Walsh MT, Love B, Hawk E. Be Well? Acres Homes: a community-driven, evidence-based approach to reduce health inequities through sustained cross-sector partnership. Cancer Causes Control. 2024 Apr; 35(4):611-622. PMID: 37979072; PMCID: PMC10960758.
      Citations:    Fields:    Translation:Humans
    7. Deng N, Reyes-Uribe L, Fahrmann JF, Thoman WS, Munsell MF, Dennison JB, Murage E, Wu R, Hawk ET, Thirumurthi S, Lynch PM, Dieli-Conwright CM, Lazar AJ, Jindal S, Chu K, Chelvanambi M, Basen-Engquist K, Li Y, Wargo JA, McAllister F, Allison JP, Sharma P, Sinha KM, Hanash S, Gilchrist SC, Vilar E. Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome. Clin Cancer Res. 2023 11 01; 29(21):4361-4372. PMID: 37724990; PMCID: PMC10618653.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    8. Batman SH, Varon ML, Daheri M, Ogburn T, Rivas SD, Guerra L, Toscano PA, Gasca M, Campos L, Foster S, Martin M, Yvette Williams-Brown M, Poindexter Y, Reininger B, Salcedo MP, Milbourne A, Fellman B, Fernandez ME, Baker E, Gowen R, Fisher-Hoch S, Rodriguez AM, Milan J, Pippin M, Hawk E, Schmeler KM. Addressing cervical cancer disparities in Texas: Expansion of a community-based prevention initiative for medically underserved populations. Prev Med Rep. 2023 Dec; 36:102486. PMID: 38021412; PMCID: PMC10660094.
      Citations:    
    9. Hatia RI, Eluri M, Hawk ET, Shalaby A, Karatas E, Shalaby A, Abdelhakeem A, Abdel-Wahab R, Chang P, Rashid A, Jalal PK, Amos CI, Han Y, Armaghany T, Shroff RT, Li D, Javle M, Hassan MM. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347. PMID: 37540502.
      Citations: 1     Fields:    Translation:Humans
    10. Cohen L, Hawk E. It Doesn't Need to Take 25 Years: Emphasizing Cancer Prevention and Control in President Biden's Cancer Moonshot. JCO Oncol Pract. 2023 10; 19(10):831-834. PMID: 37672725.
      Citations:    Fields:    Translation:Humans
    11. Colbert Maresso K, Maitra A, Hawk ET, Vilar E. From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles. Cancer Prev Res (Phila). 2023 07 05; 16(7):365-367. PMID: 37403656.
      Citations:    Fields:    Translation:Humans
    12. Bello RS, Walsh MT, Harper B, Amos CE, Oestman K, Nutt S, Galindez M, Block K, Rechis R, Bednar EM, Tektiridis J, Foxhall L, Moreno M, Shete S, Hawk E. Creating and Activating an Implementation Community to Drive HPV Vaccine Uptake in Texas: The Role of an NCI-Designated Cancer Center. Vaccines (Basel). 2023 Jun 20; 11(6). PMID: 37376517; PMCID: PMC10305309.
      Citations:    
    13. Torode JS, Tittenbrun Z, Romero Y, Johnson SE, Bourque JM, Given LS, Hohman KE, Hawk E, Stevens LM. Ten Years of the International Cancer Control Partnership: Promoting National Cancer Control Plans to Shape the Health System Response for Cancer Control. JCO Glob Oncol. 2023 01; 9:e2200232. PMID: 36630665; PMCID: PMC10166518.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Fokom Domgue J, Pande M, Yu R, Manjuh F, Welty E, Welty T, Elit L, Lopez-Varon M, Rodriguez J, Baker E, Dangou JM, Basu P, Plante M, Lecuru F, Randall T, Starr E, Kamgno J, Foxhall L, Waxman A, Hawk E, Schmeler K, Shete S. Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon. JAMA Netw Open. 2022 11 01; 5(11):e2240801. PMID: 36346631; PMCID: PMC9644259.
      Citations: 1     Fields:    Translation:Humans
    15. Berenson AB, Chang M, Hawk ET, Ramondetta LM, Hoang T. Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018. Cancer Prev Res (Phila). 2022 11 01; 15(11):777-784. PMID: 35969832.
      Citations:    
    16. Kwan SY, Sabotta CM, Joon A, Wei P, Petty LE, Below JE, Wu X, Zhang J, Jenq RR, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas. mSystems. 2022 06 28; 7(3):e0003322. PMID: 35477306; PMCID: PMC9238400.
      Citations:    
    17. Kisiel JB, Papadopoulos N, Liu MC, Crosby D, Srivastava S, Hawk ET. Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions. Cancer. 2022 02 15; 128 Suppl 4:861-874. PMID: 35133659.
      Citations: 1     Fields:    Translation:Humans
    18. Cofer J, Hurst AN, Winter T, Moreno M, Cinciripini PM, Walsh MT, Tektiridis J, Hawk E. A Comprehensive Program to Reduce Tobacco-related Cancers Through Actions by a National Cancer Institute-designated Cancer Center. Cancer Control. 2022 Jan-Dec; 29:10732748221138713. PMID: 36373741; PMCID: PMC9663624.
      Citations:    Fields:    Translation:HumansAnimals
    19. Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. Hepatology. 2022 04; 75(4):955-967. PMID: 34633706; PMCID: PMC8930512.
      Citations: 3     Fields:    Translation:HumansCells
    20. Jiao J, Kwan SY, Sabotta CM, Tanaka H, Veillon L, Warmoes MO, Lorenzi PL, Wang Y, Wei P, Hawk ET, Almeda JL, McCormick JB, Fisher-Hoch SP, Beretta L. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev. 2021 09; 30(9):1643-1651. PMID: 34155064; PMCID: PMC8419070.
      Citations:    Fields:    Translation:Humans
    21. Salcedo MP, Rodriguez AM, Fisher-Hoch S, Daheri M, Toscano PA, Gasca M, Morales J, Reyna-Rodriguez FE, Guerra M, Milbourne A, Varon ML, Reininger B, Fernandez ME, Ogburn T, Castle PE, McCormick J, Baker E, Hawk E, Schmeler KM, Gowen R, Guerra L, Cavazos B, Marin E, Perez C. Addressing high cervical cancer rates in the Rio Grande Valley along the Texas-Mexico border: a community-based initiative focused on education, patient navigation, and medical provider training/telementoring. Perspect Public Health. 2023 Jan; 143(1):22-28. PMID: 34130548.
      Citations: 1     Fields:    
    22. Rechis R, Oestman KB, Caballero E, Brewster A, Walsh MT, Basen-Engquist K, Gershenwald JE, Tektiridis JH, Moreno M, Williams PA, Treiman K, Garza PD, Hawk E. Be Well Communities?: mobilizing communities to promote wellness and stop cancer before it starts. Cancer Causes Control. 2021 Aug; 32(8):859-870. PMID: 34037915; PMCID: PMC8236479.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    23. Hawk ET, Maresso KC. The ASPREE Trial: An Unanticipated Stimulus for Greater Precision in Prevention? J Natl Cancer Inst. 2021 03 01; 113(3):221-222. PMID: 32778864; PMCID: PMC7936052.
      Citations: 1     Fields:    Translation:Humans
    24. Tami-Maury I, Suchil L, Reynales-Shigematsu LM, Garcia-Gomez L, Chen M, Shete S, Betancur A, Cinciripini PM, Hawk E, Garcia H. Cross-sectional survey for assessing cancer care providers' characteristics and attitudes on smoking cessation in Colombia and Mexico. BMJ Open. 2021 02 01; 11(2):e041447. PMID: 33526497; PMCID: PMC7852943.
      Citations:    Fields:    Translation:Humans
    25. Kripke M, Brody JG, Hawk E, Hernandez AB, Hoppin PJ, Jacobs MM, Rudel RA, Rebbeck TR. Rethinking Environmental Carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2020 10; 29(10):1870-1875. PMID: 33004408.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    26. Mantuan LA, de Oliveira MA, Junior RL, Costa AMD, Rossi S, Fava G, Taveira LN, Giardina KM, Talarico T, Costa M, Scapulatempo-Neto C, Matsushita MM, Fregnani JHT, Reis RM, Hawk ET, Mauad EC, Guimar?es DP, V?o CA. The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital. Cancer Prev Res (Phila). 2021 02; 14(2):241-252. PMID: 32998941.
      Citations: 2     Fields:    Translation:Humans
    27. Davis JS, Kanikarla-Marie P, Gagea M, Yu PL, Fang D, Sebastian M, Yang P, Hawk E, Dashwood R, Lichtenberger LM, Menter D, Kopetz S. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development. BMC Cancer. 2020 Sep 10; 20(1):871. PMID: 32912193; PMCID: PMC7488444.
      Citations: 2     Fields:    Translation:HumansAnimals
    28. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller E, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105. PMID: 32314052; PMCID: PMC9706509.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    29. Abu-Sbeih H, Ali FS, Qiao W, Lum P, Shafi MA, Bresalier RS, Hawk E, Raju GS, Wang Y. Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia. J Cancer. 2020; 11(11):3192-3198. PMID: 32231724; PMCID: PMC7097953.
      Citations:    
    30. Liao Y, Basen-Engquist KM, Urbauer DL, Bevers TB, Hawk E, Schembre SM. Using Continuous Glucose Monitoring to Motivate Physical Activity in Overweight and Obese Adults: A Pilot Study. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):761-768. PMID: 32066620; PMCID: PMC7958438.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    31. Hawk ET, Colbert Maresso K. E-Cigarettes: Unstandardized, Under-Regulated, Understudied, and Unknown Health and Cancer Risks. Cancer Res. 2019 12 15; 79(24):6079-6083. PMID: 31658978; PMCID: PMC6911629.
      Citations:    Fields:    Translation:Humans
    32. Chido-Amajuoyi OG, Mantey D, Cunningham S, Yu R, Kelder S, Hawk E, Cinciripini P, Shete S. Characteristics of us adults attempting tobacco use cessation using e-cigarettes. Addict Behav. 2020 01; 100:106123. PMID: 31605837; PMCID: PMC6905082.
      Citations: 2     Fields:    Translation:Humans
    33. Coletta AM, Marquez G, Thomas P, Thoman W, Bevers T, Brewster AM, Hawk E, Basen-Engquist K, Gilchrist SC. Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors. PLoS One. 2019; 14(8):e0220814. PMID: 31369653; PMCID: PMC6675393.
      Citations: 10     Fields:    Translation:Humans
    34. Hernandez M, Patterson DG, Hajek RA, Recinos I, Lopez DS, Li Y, Jones LA, Hawk E, Hern?ndez-Valero MA, Garc?a-Prieto C. A Pilot Study Evaluating Organochlorine and Organophosphate Pesticide Exposure in Children and Adolescents of Mexican Descent Residing in Hidalgo County, Texas. J Immigr Minor Health. 2019 Aug; 21(4):751-760. PMID: 30066057.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    35. Delacruz RGC, Sandoval IT, Chang K, Miller BN, Reyes-Uribe L, Borras E, Lynch PM, Taggart MW, Hawk ET, Vilar E, Jones DA. Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas. Oncotarget. 2019 Jun 11; 10(39):3939-3951. PMID: 31231471; PMCID: PMC6570471.
      Citations: 2     Fields:    
    36. Huey RW, Hawk E, Offodile AC. Mind the Gap: Precision Oncology and Its Potential to Widen Disparities. J Oncol Pract. 2019 06; 15(6):301-304. PMID: 31112478.
      Citations: 9     Fields:    Translation:Humans
    37. Mackert M, Case K, Lazard A, Oh J, Hughes Wagner J, Hawk E, Cofer J, Hurst A, Elerian N, Lakey D. Building a health communication brand for University of Texas System tobacco control. J Am Coll Health. 2019 May-Jun; 67(4):291-298. PMID: 29952736.
      Citations: 2     Fields:    Translation:HumansAnimals
    38. Sivakumar S, San Lucas FA, Jakubek YA, McDowell TL, Lang W, Kallsen N, Peyton S, Davies GE, Fukuoka J, Yatabe Y, Zhang J, Futreal PA, Fowler J, Fujimoto J, Ehli EA, Hawk ET, Wistuba II, Kadara H, Scheet P. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung. EBioMedicine. 2019 Apr; 42:296-303. PMID: 30905849; PMCID: PMC6491940.
      Citations: 6     Fields:    Translation:Humans
    39. Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW. Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy. Angew Chem Int Ed Engl. 2019 03 22; 58(13):4179-4183. PMID: 30680862; PMCID: PMC6467058.
      Citations: 4     Fields:    Translation:AnimalsCells
    40. Cunningham SA, Yu R, Shih T, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini P, Foxhall L, Hawk E, Shete S. Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):486-494. PMID: 30700446; PMCID: PMC6401259.
      Citations: 12     Fields:    Translation:Humans
    41. Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ET. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778. PMID: 30530635; PMCID: PMC10344465.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    42. Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Ann Oncol. 2018 10 01; 29(10):2061-2067. PMID: 30412224; PMCID: PMC6225810.
      Citations: 18     Fields:    Translation:HumansCells
    43. Hawk E, Maresso KC, Brown P. NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question. J Natl Cancer Inst. 2018 09 01; 110(9):927-928. PMID: 29554350; PMCID: PMC6136929.
      Citations: 1     Fields:    Translation:Humans
    44. Frech S, Muha CA, Stevens LM, Trimble EL, Brew R, Perin DP, Luciani S, Mohar A, Pi?eros M, Vidaurre T, Morgan DR, Hawk ET, Schmeler KM, Foxhall LE, Rabadan-Diehl C, Duran D, Rendler-Garcia M, Cazap EL, Santini L, Zoss W, Delgado LB, Pearlman PC, Given L, Hohman K, Lopez MS, Kostelecky B. Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health. J Glob Oncol. 2018 09; 4:1-11. PMID: 30241245; PMCID: PMC6223440.
      Citations: 8     Fields:    Translation:HumansAnimalsPHPublic Health
    45. Kanikarla-Marie P, Kopetz S, Hawk ET, Millward SW, Sood AK, Gresele P, Overman M, Honn K, Menter DG. Bioactive lipid metabolism in platelet "first responder" and cancer biology. Cancer Metastasis Rev. 2018 09; 37(2-3):439-454. PMID: 30112590.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    46. Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. JAMA Oncol. 2018 08 01; 4(8):1085-1092. PMID: 29710228; PMCID: PMC6087485.
      Citations: 31     Fields:    Translation:Humans
    47. Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 2018 07 01; 32(13-14):868-902. PMID: 29945886; PMCID: PMC6075032.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    48. Foxhall L, Moreno M, Hawk E. MD Anderson's Population Health Approaches to Cancer Prevention. Tex Med. 2018 02 01; 114(2):34-41. PMID: 29393960.
      Citations:    Fields:    Translation:HumansPHPublic Health
    49. Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J, Yatabe Y, Dubinett SM, Spira AE, Fowler J, Hawk ET, Wistuba II, Scheet P, Kadara H. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma. Cancer Res. 2017 11 15; 77(22):6119-6130. PMID: 28951454; PMCID: PMC5774855.
      Citations: 38     Fields:    Translation:Humans
    50. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis. Clin Cancer Res. 2017 Oct 01; 23(19):5936-5947. PMID: 28645942; PMCID: PMC5626604.
      Citations: 14     Fields:    Translation:Humans
    51. Lin SH, Raju GS, Huff C, Ye Y, Gu J, Chen JS, Hildebrandt MAT, Liang H, Menter DG, Morris J, Hawk E, Stroehlein JR, Futreal A, Kopetz S, Mishra L, Wu X. The somatic mutation landscape of premalignant colorectal adenoma. Gut. 2018 07; 67(7):1299-1305. PMID: 28607096; PMCID: PMC6031265.
      Citations: 30     Fields:    Translation:Humans
    52. Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV. Platelet "first responders" in wound response, cancer, and metastasis. Cancer Metastasis Rev. 2017 06; 36(2):199-213. PMID: 28730545; PMCID: PMC5709140.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    53. Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 2017 06; 36(2):289-303. PMID: 28762014; PMCID: PMC5557878.
      Citations: 57     Fields:    Translation:HumansAnimalsCells
    54. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799. PMID: 28579181; PMCID: PMC5901750.
      Citations: 33     Fields:    Translation:Humans
    55. Davis JS, Lee HY, Kim J, Advani SM, Peng HL, Banfield E, Hawk ET, Chang S, Frazier-Wood AC. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Heart. 2017; 4(1):e000550. PMID: 28674622; PMCID: PMC5471872.
      Citations: 37     Fields:    
    56. Hurd TC, Kaplan CD, Cook ED, Chilton JA, Lytton JS, Hawk ET, Jones LA. Building trust and diversity in patient-centered oncology clinical trials: An integrated model. Clin Trials. 2017 Apr; 14(2):170-179. PMID: 28166647.
      Citations: 9     Fields:    Translation:Humans
    57. Tripp MK, Gershenwald JE, Davies MA, Garcia J, Gritz ER, Hawk ET, Peterson SK. Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors. JAMA Dermatol. 2017 Feb 01; 153(2):228-229. PMID: 27829081; PMCID: PMC5484732.
      Citations: 7     Fields:    
    58. Lopez MS, Baker ES, Milbourne AM, Gowen RM, Rodriguez AM, Lorenzoni C, Mwaba C, Msadabwe SC, Fontes-Cintra G, Zucca-Matthes G, Callegaro-Filho D, Ramos-Martin D, Thiago de Carvalho I, Coelho R, Marques RM, Chulam T, Pontremoli-Salcedo M, Nozar F, Fiol V, Maza M, Arora S, Hawk ET, Schmeler KM, Tavares JH. Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource Settings. J Glob Oncol. 2017 Oct; 3(5):658-665. PMID: 29094102; PMCID: PMC5646881.
      Citations: 20     Fields:    
    59. Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, Shen J, Takata Y, McNiece K, Polansky MA, Abbas HA, Rajapakshe K, Gower A, Spira A, Covington KR, Xiao W, Gunaratne P, Pickering C, Frederick M, Myers JN, Shen L, Yao H, Su X, Rapini RP, Wheeler DA, Hawk ET, Flores ER, Tsai KY. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nat Commun. 2016 08 30; 7:12601. PMID: 27574101; PMCID: PMC5013636.
      Citations: 50     Fields:    Translation:HumansAnimals
    60. Maresso KC, Hawk E. Cancer Prevention Recommendations: Impact of Adherence. Semin Oncol Nurs. 2016 08; 32(3):306-13. PMID: 27539284.
      Citations: 1     Fields:    Translation:Humans
    61. Hawk ET. Ernest Hawk Discusses the NCI-Designated Cancer Centers' Joint Statement on the HPV Vaccine. Oncology (Williston Park). 2016 Jul; 30(7):599-600. PMID: 27422108.
      Citations:    Fields:    Translation:Humans
    62. Vilar E, Maresso KC, Hawk ET. Aspirin for Cancer Prevention: One Step Closer. JAMA Oncol. 2016 Jun 01; 2(6):770-1. PMID: 26939883.
      Citations: 1     Fields:    Translation:Humans
    63. Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E. Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prev Res (Phila). 2016 06; 9(6):417-27. PMID: 27221540; PMCID: PMC4941624.
      Citations: 42     Fields:    Translation:HumansCells
    64. DePinho RA, Hawk E. Cancer prevention in developing countries: a vision for preserving health in Mexico. Salud Publica Mex. 2016 Apr; 58(2):93-6. PMID: 27557366.
      Citations:    Fields:    Translation:HumansPHPublic Health
    65. Hildebrandt MA, Reyes ME, Lin M, He Y, Nguyen SV, Hawk ET, Wu X. Germline Genetic Variants in the Wnt/?-Catenin Pathway as Predictors of Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):540-6. PMID: 26809274; PMCID: PMC4779688.
      Citations: 7     Fields:    Translation:HumansCells
    66. Tsai KY, Hawk ET. When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial Design. Cancer Prev Res (Phila). 2016 Feb; 9(2):125-7. PMID: 26714773.
      Citations:    Fields:    Translation:Humans
    67. Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR. Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC). Int J Epidemiol. 2016 06; 45(3):713-713f. PMID: 26686840; PMCID: PMC5841601.
      Citations: 10     Fields:    Translation:Humans
    68. Umar A, Steele VE, Menter DG, Hawk ET. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention. Semin Oncol. 2016 Feb; 43(1):65-77. PMID: 26970125.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    69. Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET. Molecular cancer prevention: Current status and future directions. CA Cancer J Clin. 2015 Sep-Oct; 65(5):345-83. PMID: 26284997; PMCID: PMC4820069.
      Citations: 41     Fields:    Translation:Humans
    70. Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29. PMID: 25836985; PMCID: PMC4778392.
      Citations: 38     Fields:    Translation:Humans
    71. Lynch PM, Burke CA, Phillips R, Morris JS, Slack R, Wang X, Liu J, Patterson S, Sinicrope FA, Rodriguez-Bigas MA, Half E, Bulow S, Latchford A, Clark S, Ross WA, Malone B, Hasson H, Richmond E, Hawk E. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 2016 Feb; 65(2):286-95. PMID: 25792707.
      Citations: 31     Fields:    Translation:Humans
    72. Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient? JAMA. 2014 Sep 24; 312(12):1193-4. PMID: 25247511; PMCID: PMC4367127.
      Citations: 13     Fields:    Translation:Humans
    73. Akiyama J, Alexandre L, Baruah A, Buttar N, Chandra R, Clark AB, Hart AR, Hawk E, Kandioler D, Kappel S, Krishnadath SK, Sharma A, Singh I, Straub D, Triadafilopoulos G, Umar A, Wolf B. Strategy for prevention of cancers of the esophagus. Ann N Y Acad Sci. 2014 Sep; 1325:108-26. PMID: 25266020.
      Citations: 6     Fields:    Translation:HumansAnimals
    74. Colbert Maresso K, Vilar E, Hawk ET. Urinary PGE-M in colorectal cancer: predicting more than risk? Cancer Prev Res (Phila). 2014 Oct; 7(10):969-72. PMID: 25070664; PMCID: PMC4185234.
      Citations: 6     Fields:    Translation:Humans
    75. Menter DG, Patterson SL, Logsdon CD, Kopetz S, Sood AK, Hawk ET. Convergence of nanotechnology and cancer prevention: are we there yet? Cancer Prev Res (Phila). 2014 Oct; 7(10):973-92. PMID: 25060262; PMCID: PMC4307396.
      Citations: 2     Fields:    Translation:Humans
    76. Satcher RL, Bogler O, Hyle L, Lee A, Simmons A, Williams R, Hawk E, Matin S, Brewster AM. Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center. J Surg Oncol. 2014 Sep; 110(4):353-9. PMID: 24889208.
      Citations: 10     Fields:    Translation:Humans
    77. Hawk ET, Habermann EB, Ford JG, Wenzel JA, Brahmer JR, Chen MS, Jones LA, Hurd TC, Rogers LM, Nguyen LH, Ahluwalia JS, Fouad M, Vickers SM. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement. Cancer. 2014 Apr 01; 120 Suppl 7:1113-21. PMID: 24643649; PMCID: PMC4322861.
      Citations: 16     Fields:    Translation:Humans
    78. Herbst RS, Hobin JA, Gritz ER, Writing Committee for the AACR Subcommittee on Tobacco and Cancer. AACR celebrates 50 years of tobacco research and policy. Clin Cancer Res. 2014 Apr 01; 20(7):1709-18. PMID: 24691637.
      Citations:    Fields:    Translation:HumansAnimals
    79. Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2013 Dec; 34(12):2750-6. PMID: 23996928; PMCID: PMC3845893.
      Citations: 21     Fields:    Translation:HumansCells
    80. Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47. PMID: 23776098; PMCID: PMC3808509.
      Citations: 25     Fields:    Translation:Humans
    81. Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31; 382(9894):769-79. PMID: 23726390; PMCID: PMC3778977.
      Citations: 430     Fields:    Translation:Humans
    82. Raju GS, Vadyala V, Slack R, Krishna SG, Ross WA, Lynch PM, Bresalier RS, Hawk E, Stroehlein JR. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med. 2013 Jun; 2(3):391-402. PMID: 23930215; PMCID: PMC3699850.
      Citations: 11     Fields:    Translation:Humans
    83. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013 Mar; 6(3):196-205. PMID: 23466817; PMCID: PMC3608471.
      Citations: 53     Fields:    Translation:HumansCells
    84. Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Daniel K, Deng G, Djeu J, Dou J, Hawk E, Jayaram B, Jia L, Joshi R, Kararala M, Karunagaran D, Kucuk O, Kumar L, Malafa M, Samathanam GJ, Sarkar F, Siddiqi M, Singh RP, Srivastava A, White JD. Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival. Cancer Med. 2013 Feb; 2(1):108-15. PMID: 24279005; PMCID: PMC3797562.
      Citations: 1     Fields:    Translation:Humans
    85. Brenner DE, Hawk E. Trials and tribulations of interrogating biomarkers to define efficacy of cancer risk reductive interventions. Cancer Prev Res (Phila). 2013 Feb; 6(2):71-3. PMID: 23333813; PMCID: PMC4139927.
      Citations: 3     Fields:    Translation:Humans
    86. Patterson SL, Colbert Maresso K, Hawk E. Cancer chemoprevention: successes and failures. Clin Chem. 2013 Jan; 59(1):94-101. PMID: 23150056.
      Citations: 22     Fields:    Translation:Humans
    87. Wen CP, Lin J, Yang YC, Tsai MK, Tsao CK, Etzel C, Huang M, Hsu CY, Ye Y, Mishra L, Hawk E, Wu X. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J Natl Cancer Inst. 2012 Oct 17; 104(20):1599-611. PMID: 23073549; PMCID: PMC3692381.
      Citations: 44     Fields:    Translation:Humans
    88. Lin M, Eng C, Hawk ET, Huang M, Lin J, Gu J, Ellis LM, Wu X. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma. Cancer. 2012 Dec 15; 118(24):6188-98. PMID: 22673945; PMCID: PMC3465518.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    89. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91. PMID: 22661538; PMCID: PMC4141857.
      Citations: 35     Fields:    Translation:Humans
    90. Cialdella-Kam L, Sabado P, Bispeck MK, Silverman S, Bernstein L, Krawiec V, Hawk E, O'Donnell JF. Implementing cancer prevention into clinical practice. J Cancer Educ. 2012 May; 27(2 Suppl):S136-43. PMID: 22367592; PMCID: PMC4126604.
      Citations: 3     Fields:    Translation:Humans
    91. Dai J, Gu J, Huang M, Eng C, Kopetz ES, Ellis LM, Hawk E, Wu X. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis. 2012 Jul; 33(7):1327-31. PMID: 22505654; PMCID: PMC4072910.
      Citations: 30     Fields:    Translation:Humans
    92. Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X. Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk. Int J Cancer. 2012 Oct 15; 131(8):1892-903. PMID: 22261697; PMCID: PMC3415602.
      Citations: 9     Fields:    Translation:Humans
    93. Arber N, Lieberman D, Wang TC, Zhang R, Sands GH, Bertagnolli MM, Hawk ET, Eagle C, Coindreau J, Zauber A, Lanas A, Levin B. The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo. Clin Ther. 2012 Mar; 34(3):569-79. PMID: 22386831.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    94. Lin M, Eng C, Hawk ET, Huang M, Greisinger AJ, Gu J, Ellis LM, Wu X, Lin J. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma. Carcinogenesis. 2012 Apr; 33(4):841-7. PMID: 22318908; PMCID: PMC3324446.
      Citations: 3     Fields:    Translation:HumansCells
    95. Ross W, Lynch P, Raju G, Rodriguez A, Burke T, Hafemeister L, Hawk E, Wu X, Dubois RN, Mishra L. Biomarkers, bundled payments, and colorectal cancer care. Genes Cancer. 2012 Jan; 3(1):16-22. PMID: 22893787; PMCID: PMC3415669.
      Citations: 4     
    96. Chan AT, Hsu M, Zauber AG, Hawk ET, Bertagnolli MM. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila). 2012 Jan; 5(1):61-72. PMID: 22030088; PMCID: PMC3252487.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    97. Wu X, Patterson S, Hawk E. Chemoprevention--history and general principles. Best Pract Res Clin Gastroenterol. 2011 Aug; 25(4-5):445-59. PMID: 22122762.
      Citations: 14     Fields:    Translation:HumansAnimals
    98. Chan AT, Sima CS, Zauber AG, Ridker PM, Hawk ET, Bertagnolli MM. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila). 2011 Aug; 4(8):1172-80. PMID: 21816845; PMCID: PMC3151679.
      Citations: 12     Fields:    Translation:Humans
    99. Fischer SM, Hawk ET, Lubet RA. Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila). 2011 Nov; 4(11):1728-35. PMID: 21778329; PMCID: PMC3208782.
      Citations: 55     Fields:    Translation:HumansAnimals
    100. Brewster AM, Patterson SL, Forman MR, Hughes-Halbert C, Limburg PJ, Ondrey FG, Paskett ED, Wetter DW, Hawk ET. Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prev Res (Phila). 2010 Aug; 3(8):1044-8. PMID: 20663980.
      Citations: 1     Fields:    Translation:Humans
    101. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila). 2010 Sep; 3(9):1176-86. PMID: 20651033; PMCID: PMC3932797.
      Citations: 45     Fields:    Translation:Humans
    102. Hawk E, Patterson S. Modelling a dream: the molecular prevention of pancreatic cancer. Gut. 2010 May; 59(5):566-8. PMID: 20427387.
      Citations: 1     Fields:    Translation:HumansAnimals
    103. Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG, Adenoma Prevention with Celecoxib (APC) Study Investigators. Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila). 2010 May; 3(5):588-96. PMID: 20403998; PMCID: PMC2990920.
      Citations: 16     Fields:    Translation:Humans
    104. Lin J, Wang J, Greisinger AJ, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res (Phila). 2010 Apr; 3(4):505-17. PMID: 20354165; PMCID: PMC2867666.
      Citations: 15     Fields:    Translation:HumansCells
    105. Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M, Church J, Hasson H, Patterson S, Half E, Burke CA. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010 Jun; 105(6):1437-43. PMID: 20234350.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    106. Hawk E, Patterson S. Aspirin: anticolorectal adenocarcinoma activity in the adjuvant arena? Future Oncol. 2010 Feb; 6(2):197-200. PMID: 20146578.
      Citations:    Fields:    
    107. Lippman SM, Hawk ET. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009 Jul 01; 69(13):5269-84. PMID: 19491253.
      Citations: 49     Fields:    Translation:Humans
    108. Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D, Charabaty A, Chia D, Umar A, Viner J, Hawk E, Pinsky PF. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009 May; 7(5):568-74. PMID: 19418605.
      Citations: 19     Fields:    Translation:Humans
    109. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET, Adenoma Prevention with Celecoxib Study Investigators. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila). 2009 Apr; 2(4):310-21. PMID: 19336730; PMCID: PMC2976587.
      Citations: 87     Fields:    Translation:Humans
    110. Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM. Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology. 2009 Jun; 136(7):2127-2136.e1. PMID: 19233181; PMCID: PMC2693443.
      Citations: 22     Fields:    Translation:Humans
    111. Hawk E, Guillem JG. Improving the vision of colonoscopy: does the fine print really matter? Cancer Prev Res (Phila). 2008 Dec; 1(7):495-8. PMID: 19138997.
      Citations:    Fields:    Translation:HumansPHPublic Health
    112. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. PMID: 18990728.
      Citations: 1     Fields:    Translation:Humans
    113. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prev Res (Phila). 2008 Nov; 1(6):393-5. PMID: 19138984.
      Citations:    Fields:    Translation:Humans
    114. Hawk ET, Greenwood A, Gritz ER, McTiernan A, Sellers T, Hursting SD, Leischow S, Grad O, Translational Research Working Group. The Translational Research Working Group developmental pathway for lifestyle alterations. Clin Cancer Res. 2008 Sep 15; 14(18):5707-13. PMID: 18794079.
      Citations: 1     Fields:    Translation:Humans
    115. Srivastava S, Gray JW, Reid BJ, Grad O, Greenwood A, Hawk ET, Translational Research Working Group. Translational Research Working Group developmental pathway for biospecimen-based assessment modalities. Clin Cancer Res. 2008 Sep 15; 14(18):5672-7. PMID: 18794074; PMCID: PMC2737183.
      Citations: 11     Fields:    Translation:Humans
    116. Hawk ET, Matrisian LM, Nelson WG, Dorfman GS, Stevens L, Kwok J, Viner J, Hautala J, Grad O, Translational Research Working Group. The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res. 2008 Sep 15; 14(18):5664-71. PMID: 18612047.
      Citations: 13     Fields:    Translation:Humans
    117. Meyskens FL, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):32-8. PMID: 18841250; PMCID: PMC2562024.
      Citations: 244     Fields:    Translation:Humans
    118. Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila). 2008 Jun; 1(1):21-31. PMID: 19138933.
      Citations: 25     Fields:    Translation:Humans
    119. Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, Pater JL, Goss PE, Lance P, Obara S, Chew EY, Kim J, Arndt G, Hawk E, Cross Trial Safety Assessment Group. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 2008 Apr 22; 117(16):2104-13. PMID: 18378608; PMCID: PMC2965408.
      Citations: 118     Fields:    Translation:Humans
    120. Hawk ET, Viner JL. Statins in esophageal cancer cell lines: promising lead? Am J Gastroenterol. 2008 Apr; 103(4):838-41. PMID: 18371147.
      Citations: 3     Fields:    Translation:AnimalsCells
    121. Heath EI, Canto MI, Piantadosi S, Montgomery E, Weinstein WM, Herman JG, Dannenberg AJ, Yang VW, Shar AO, Hawk E, Forastiere AA, Chemoprevention for Barrett's Esophagus Trial Research Group. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst. 2007 Apr 04; 99(7):545-57. PMID: 17405999; PMCID: PMC3755596.
      Citations: 72     Fields:    Translation:HumansCellsCTClinical Trials
    122. Hawk E, Viner JL. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress. Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):185-7. PMID: 17301246.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    123. Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomon D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A, Workshop Program Committee. Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 2007; 3(1):1-33. PMID: 17655039.
      Citations: 8     Fields:    Translation:Humans
    124. Hawk E, Viner JL. What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S6-9. PMID: 17178278.
      Citations: 2     Fields:    Translation:Humans
    125. Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Zauber AG, Bertagnolli MM, Arber N, Wittes J, APC and PreSAP Trial Investigators, Lechuga M. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation. 2006 Sep 05; 114(10):1028-35. PMID: 16943394.
      Citations: 80     Fields:    Translation:HumansCTClinical Trials
    126. Hawk ET, Viner JL. Do statins prevent cancer? Nat Clin Pract Oncol. 2006 Sep; 3(9):478-9. PMID: 16955084.
      Citations:    Fields:    Translation:Humans
    127. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET, APC Study Investigators, Boisserie F. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006 Aug 31; 355(9):873-84. PMID: 16943400.
      Citations: 381     Fields:    Translation:HumansPHPublic Health
    128. Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL, Kirsch IR. Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res. 2006 Jul 01; 66(13):6851-60. PMID: 16818663.
      Citations: 15     Fields:    Translation:Humans
    129. Glebov OK, Rodriguez LM, Lynch P, Patterson S, Lynch H, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, Denobile J, Soballe P, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR. Celecoxib treatment alters the gene expression profile of normal colonic mucosa. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7):1382-91. PMID: 16835340.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    130. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK, AACR Task Force on Cancer Prevention. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. PMID: 16778094.
      Citations: 88     Fields:    Translation:HumansCells
    131. Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL, Kirsch IR. Selenomethionine treatment does not alter gene expression in normal squamous esophageal mucosa in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):1046-7. PMID: 16702392.
      Citations: 1     Fields:    Translation:Humans
    132. Jankowski JA, Hawk ET. A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer. Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):101-11. PMID: 16456576.
      Citations: 9     Fields:    Translation:Humans
    133. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer. 2005 Dec; 5(12):930-42. PMID: 16341084.
      Citations: 307     Fields:    Translation:HumansAnimals
    134. Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, Giffen CA, Wang G, Roth MJ, Lu N, Korn EL, Ma Y, Caldwell KL, Dong Z, Taylor PR, Dawsey SM. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology. 2005 Sep; 129(3):863-73. PMID: 16143126.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    135. Hawk E, Viner JL. Statins and cancer--beyond the "one drug, one disease" model. N Engl J Med. 2005 May 26; 352(21):2238-9. PMID: 15917390.
      Citations: 8     Fields:    Translation:Humans
    136. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M, Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005 Mar 17; 352(11):1071-80. PMID: 15713944.
      Citations: 523     Fields:    Translation:HumansCTClinical Trials
    137. Hawk E, Viner JL. The critical role of risk-benefit assessments in cancer prevention. Cancer Epidemiol Biomarkers Prev. 2005 Feb; 14(2):297-8. PMID: 15734949.
      Citations:    Fields:    Translation:Humans
    138. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol. 2005 Jan 10; 23(2):378-91. PMID: 15637400.
      Citations: 67     Fields:    Translation:Humans
    139. Hawk ET, Umar A, Richmond E, Viner JL. Prevention and therapy of colorectal cancer. Med Clin North Am. 2005 Jan; 89(1):85-110, viii. PMID: 15527810.
      Citations: 1     Fields:    Translation:Humans
    140. Hawk ET, Umar A, Lubet RA, Kopelovich L, Viner JL. Can animal models help us select specific compounds for cancer prevention trials? Recent Results Cancer Res. 2005; 166:71-87. PMID: 15648184.
      Citations: 3     Fields:    Translation:HumansAnimals
    141. Lam S, leRiche JC, McWilliams A, Macaulay C, Dyachkova Y, Szabo E, Mayo J, Schellenberg R, Coldman A, Hawk E, Gazdar A. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res. 2004 Oct 01; 10(19):6502-11. PMID: 15475437.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    142. Lippman SM, Levin B, Brenner DE, Gordon GB, Aldige CR, Kramer BS, Garber JE, Hawk E, Ganz PA, Somerfield MR, Writing Committee of the ASCO Cancer Prevention Committee. Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51. PMID: 15353541.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    143. Jacoby RF, Cole CE, Hawk ET, Lubet RA. Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Gastroenterology. 2004 Sep; 127(3):838-44. PMID: 15362039.
      Citations: 11     Fields:    Translation:Animals
    144. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res. 2004 Sep-Oct; 24(5B):3177-84. PMID: 15510608.
      Citations: 52     Fields:    Translation:Humans
    145. Lao CD, Backoff P, Shotland LI, McCarty D, Eaton T, Ondrey FG, Viner JL, Spechler SJ, Hawk ET, Brenner DE. Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1250-2. PMID: 15247138.
      Citations: 10     Fields:    Translation:Humans
    146. Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC, Familial Adenomatous Polyposis Study Group. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):920-7. PMID: 15184247.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    147. Hawk ET, Umar A, Viner JL. Colorectal cancer chemoprevention--an overview of the science. Gastroenterology. 2004 May; 126(5):1423-47. PMID: 15131803.
      Citations: 11     Fields:    Translation:Humans
    148. Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU. Serum proteomic profiles suggest celecoxib-modulated targets and response predictors. Cancer Res. 2004 Apr 15; 64(8):2904-9. PMID: 15087410.
      Citations: 7     Fields:    Translation:Humans
    149. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S, R?schoff J, Peltomaki P. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8. PMID: 14970275; PMCID: PMC2933058.
      Citations: 1100     Fields:    Translation:HumansCells
    150. Umar A, Risinger JI, Hawk ET, Barrett JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer. 2004 02; 4(2):153-8. PMID: 14964310.
      Citations: 54     Fields:    Translation:HumansCells
    151. Anderson WF, Umar A, Hawk ET. Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin Pharmacother. 2003 Dec; 4(12):2193-204. PMID: 14640918.
      Citations: 5     Fields:    Translation:Humans
    152. Hawk ET, Viner JL. Aspirin: still learning about the wonder drug. Gut. 2003 Nov; 52(11):1535-6. PMID: 14570718; PMCID: PMC1773852.
      Citations: 1     Fields:    Translation:Humans
    153. Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman SM. Frontiers in cancer prevention research. Cancer Res. 2003 Sep 15; 63(18):5649-55. PMID: 14522879.
      Citations: 2     Fields:    Translation:Humans
    154. Umar A, Viner JL, Anderson WF, Hawk ET. Development of COX inhibitors in cancer prevention and therapy. Am J Clin Oncol. 2003 Aug; 26(4):S48-57. PMID: 12902856.
      Citations: 1     Fields:    Translation:HumansAnimals
    155. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):755-62. PMID: 12917207.
      Citations: 117     Fields:    Translation:Humans
    156. Kelloff GJ, O'Shaughnessy JA, Gordon GB, Hawk ET, Sigman CC. Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):593-6. PMID: 12869396.
      Citations: 3     Fields:    Translation:Humans
    157. Steele VE, Hawk ET, Viner JL, Lubet RA. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res. 2003 Feb-Mar; 523-524:137-44. PMID: 12628511.
      Citations: 17     Fields:    Translation:Humans
    158. Hawk ET, Viner J, Richmond E, Umar A. Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. Cancer Chemother Biol Response Modif. 2003; 21:759-89. PMID: 15338773.
      Citations: 2     Fields:    Translation:HumansAnimals
    159. Heath EI, Canto MI, Wu TT, Piantadosi S, Hawk E, Unalp A, Gordon G, Forastiere AA, CBET Research Group. Chemoprevention for Barrett's esophagus trial. Design and outcome measures. Dis Esophagus. 2003; 16(3):177-86. PMID: 14641306.
      Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
    160. Hawk ET, Viner JL, Umar A. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials. Prog Exp Tumor Res. 2003; 37:210-42. PMID: 12795057.
      Citations: 3     Fields:    Translation:Humans
    161. Viner JL, Umar A, Hawk ET. Chemoprevention of colorectal cancer: problems, progress, and prospects. Gastroenterol Clin North Am. 2002 Dec; 31(4):971-99. PMID: 12489273.
      Citations: 4     Fields:    Translation:Humans
    162. Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin North Am. 2002 Oct; 82(5):905-41. PMID: 12507200.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    163. Anderson WF, Guyton KZ, Hiatt RA, Vernon SW, Levin B, Hawk E. Colorectal cancer screening for persons at average risk. J Natl Cancer Inst. 2002 Aug 07; 94(15):1126-33. PMID: 12165637.
      Citations: 28     Fields:    Translation:Humans
    164. Lam S, MacAulay C, Le Riche JC, Dyachkova Y, Coldman A, Guillaud M, Hawk E, Christen MO, Gazdar AF. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst. 2002 Jul 03; 94(13):1001-9. PMID: 12096085.
      Citations: 40     Fields:    Translation:HumansCellsCTClinical Trials
    165. Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G, FAP Study Group. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002 Jun; 50(6):857-60. PMID: 12010890; PMCID: PMC1773237.
      Citations: 112     Fields:    Translation:HumansCTClinical Trials
    166. Hawk ET, Viner JL, Dannenberg A, DuBois RN. COX-2 in cancer--a player that's defining the rules. J Natl Cancer Inst. 2002 Apr 17; 94(8):545-6. PMID: 11959883.
      Citations: 19     Fields:    Translation:Humans
    167. Umar A, Viner JL, Richmond E, Anderson WF, Hawk ET. Chemoprevention of colorectal carcinogenesis. Int J Clin Oncol. 2002 Feb; 7(1):2-26. PMID: 11942045.
      Citations: 4     Fields:    Translation:HumansAnimals
    168. Anderson WF, Umar A, Viner JL, Hawk ET. The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002; 8(12):1035-62. PMID: 11945150.
      Citations: 8     Fields:    Translation:HumansAnimals
    169. Umar A, Viner JL, Hawk ET. The future of colon cancer prevention. Ann N Y Acad Sci. 2001 Dec; 952:88-108. PMID: 11795446.
      Citations: 7     Fields:    Translation:HumansAnimals
    170. Demark-Wahnefried W, Schildkraut JM. Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):415-6. PMID: 11319187.
      Citations: 1     Fields:    Translation:Humans
    171. Dimitrov NV, Leece CM, Tompkins ER, Seymour E, Bennink M, Gardiner J, Crowell J, Hawk E, Nashawaty M, Bennett JL. Oltipraz concentrations in plasma, buccal mucosa cells, and lipids: pharmacological studies. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):201-7. PMID: 11303588.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    172. Anderson WF, Hawk E, Berg CD. Secondary chemoprevention of upper aerodigestive tract tumors. Semin Oncol. 2001 Feb; 28(1):106-20. PMID: 11254870.
      Citations: 3     Fields:    Translation:Humans
    173. Hawk ET, Viner JL. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research. Ann Intern Med. 2001 Jan 16; 134(2):158-60. PMID: 11177320.
      Citations: 1     Fields:    Translation:Humans
    174. Kelloff GJ, Sigman CC, Hawk ET, Johnson KM, Crowell JA, Guyton KZ. Surrogate end-point biomarkers in chemopreventive drug development. IARC Sci Publ. 2001; 154:13-26. PMID: 11220652.
      Citations: 1     Fields:    Translation:Humans
    175. Precancerous lesions of the digestive tract. The 18th Annual Symposium of the European Cancer Prevention Organization. Maastricht, The Netherlands. 12-14 October 2000. Abstracts. Eur J Cancer Prev. 2000 Dec; 9(6):443-63. PMID: 11263399.
      Citations:    Fields:    Translation:Humans
    176. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ. Potential use of lipoxygenase inhibitors for cancer chemoprevention. Expert Opin Investig Drugs. 2000 Sep; 9(9):2121-38. PMID: 11060797.
      Citations: 6     Fields:    Translation:HumansAnimals
    177. Hawk ET, Lippman SM. Primary cancer prevention trials. Hematol Oncol Clin North Am. 2000 Aug; 14(4):809-30. PMID: 10949775.
      Citations: 5     Fields:    Translation:Humans
    178. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52. PMID: 10874062.
      Citations: 527     Fields:    Translation:HumansCTClinical Trials
    179. Hawk E, Viner JL, Lawrence JA. Biomarkers as surrogates for cancer development. Curr Oncol Rep. 2000 May; 2(3):242-50. PMID: 11122849.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    180. Hawk E, Breslow RA, Graubard BI. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):523-7. PMID: 10815699.
      Citations: 21     Fields:    Translation:Humans
    181. Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, Lubet RA. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res. 2000 Apr 01; 60(7):1864-70. PMID: 10766173.
      Citations: 35     Fields:    Translation:Animals
    182. Heath EI, Limburg PJ, Hawk ET, Forastiere AA. Adenocarcinoma of the esophagus: risk factors and prevention. Oncology (Williston Park). 2000 Apr; 14(4):507-14; discussion 518-20, 522-3. PMID: 10826312.
      Citations: 8     Fields:    Translation:Humans
    183. Kelloff GJ, Sigman CC, Johnson KM, Boone CW, Greenwald P, Crowell JA, Hawk ET, Doody LA. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2000 Feb; 9(2):127-37. PMID: 10698472.
      Citations: 17     Fields:    Translation:Humans
    184. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr. 2000 02; 130(2S Suppl):467S-471S. PMID: 10721931.
      Citations: 81     Fields:    Translation:Humans
    185. van Stolk R, Stoner G, Hayton WL, Chan K, DeYoung B, Kresty L, Kemmenoe BH, Elson P, Rybicki L, Church J, Provencher K, McLain D, Hawk E, Fryer B, Kelloff G, Ganapathi R, Budd GT. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res. 2000 Jan; 6(1):78-89. PMID: 10656435.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    186. Hawk E, Lubet R, Limburg P. Chemoprevention in hereditary colorectal cancer syndromes. Cancer. 1999 Dec 01; 86(11 Suppl):2551-63. PMID: 10630181.
      Citations: 17     Fields:    Translation:Humans
    187. McCaskill-Stevens W, Hawk ET, Flynn PJ, Lippman SM. National Cancer Institute--supported cancer chemoprevention research: coming of age. J Clin Oncol. 1999 Nov; 17(11 Suppl):53-62. PMID: 10630263.
      Citations:    Fields:    Translation:Humans
    188. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev. 1999 May; 8(5):467-83. PMID: 10350444.
      Citations: 58     Fields:    Translation:HumansAnimals
    189. Lam S, leRiche JC, Zheng Y, Coldman A, MacAulay C, Hawk E, Kelloff G, Gazdar AF. Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J Natl Cancer Inst. 1999 Apr 21; 91(8):691-6. PMID: 10218506.
      Citations: 15     Fields:    Translation:Humans
    190. Li H, Schut HA, Conran P, Kramer PM, Lubet RA, Steele VE, Hawk EE, Kelloff GJ, Pereira MA. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis. 1999 Mar; 20(3):425-30. PMID: 10190557.
      Citations: 23     Fields:    Translation:Animals
    191. Shao J, Sheng H, Aramandla R, Pereira MA, Lubet RA, Hawk E, Grogan L, Kirsch IR, Washington MK, Beauchamp RD, DuBois RN. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis. 1999 Feb; 20(2):185-91. PMID: 10069452.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    192. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, Hawk ET, Lieberman R, Lawrence JA, Kopelovich L, Ali I, Viner JL, Sigman CC. Progress in cancer chemoprevention. Ann N Y Acad Sci. 1999; 889:1-13. PMID: 10668477.
      Citations: 13     Fields:    Translation:HumansAnimals
    193. Stoner GD, Budd GT, Ganapathi R, DeYoung B, Kresty LA, Nitert M, Fryer B, Church JM, Provencher K, Pamukcu R, Piazza G, Hawk E, Kelloff G, Elson P, van Stolk RU. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol. 1999; 470:45-53. PMID: 10709673.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    194. Lieberman R, Crowell JA, Hawk ET, Boone CW, Sigman CC, Kelloff GJ. Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring. Clin Chem. 1998 Feb; 44(2):420-7. PMID: 9474054.
      Citations: 7     Fields:    Translation:Humans
    195. Kelloff GJ, Lubet RA, Lieberman R, Eisenhauer K, Steele VE, Crowell JA, Hawk ET, Boone CW, Sigman CC. Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):65-78. PMID: 9456245.
      Citations: 8     Fields:    Translation:Humans
    196. Kelloff GJ, Hawk ET, Karp JE, Crowell JA, Boone CW, Steele VE, Lubet RA, Sigman CC. Progress in clinical chemoprevention. Semin Oncol. 1997 Apr; 24(2):241-52. PMID: 9129692.
      Citations: 7     Fields:    Translation:Humans
    197. Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk ET, Steele VE, Lubet RA, Sigman CC. Perspectives and progress in development of breast cancer chemopreventive drugs. Prog Clin Biol Res. 1997; 396:159-83. PMID: 9108597.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    198. Kelloff GJ, Hawk ET, Crowell JA, Boone CW, Steele VE, Lubet RA, Sigman CC. Perspectives on chemoprevention agent selection and short-term clinical prevention trials. Eur J Cancer Prev. 1996 Dec; 5 Suppl 2:79-85. PMID: 9061299.
      Citations:    Fields:    Translation:Humans
    199. Kelloff GJ, Hawk ET, Crowell JA, Boone CW, Nayfield SG, Perloff M, Steele VE, Lubet RA. Strategies for identification and clinical evaluation of promising chemopreventive agents. Oncology (Williston Park). 1996 Oct; 10(10):1471-84; discussion 1484-8. PMID: 8905841.
      Citations: 7     Fields:    Translation:HumansAnimals
    200. Rao KV, Detrisac CJ, Steele VE, Hawk ET, Kelloff GJ, McCormick DL. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis. 1996 Jul; 17(7):1435-8. PMID: 8706245.
      Citations: 19     Fields:    Translation:HumansAnimals
    201. Hawk E, Prindiville S, Kelloff G. NSAID trials, sporadic adenomas, and conservative inferences. Gastroenterology. 1996 Feb; 110(2):654-5. PMID: 8566622.
      Citations: 1     Fields:    Translation:Humans
    202. Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Malone WF, Steele VE, Lubet RA, Sigman CC. Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl. 1996; 25:1-14. PMID: 9027592.
      Citations: 12     Fields:    Translation:HumansAnimals
    203. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC. New agents for cancer chemoprevention. J Cell Biochem Suppl. 1996; 26:1-28. PMID: 9154166.
      Citations: 22     Fields:    Translation:HumansAnimals
    204. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC. Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl. 1996; 26:54-71. PMID: 9154168.
      Citations: 22     Fields:    Translation:HumansAnimals
    205. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet RA, Greenwald P, Hawk ET, Fay JR, Sigman CC. Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci Publ. 1996; (139):203-19. PMID: 8923032.
      Citations: 7     Fields:    Translation:Humans
    206. Kelloff GJ, Boone CW, Crowell JA, Nayfield SG, Hawk E, Steele VE, Lubet RA, Sigman CC. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary. J Cell Biochem Suppl. 1995; 23:1-9. PMID: 8747372.
      Citations: 5     Fields:    Translation:Humans
    207. Response to letter regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas" [2]. Circulation. 115.
    208. Cancer and the cyclo-oxygenase enzyme. American Journal of Cancer. 2:27-55.
    209. Introduction. Seminars in Oncology Nursing.
    210. Clinical development plans for cancer chemopreventive agents. Journal of Cellular Biochemistry. 63:72-315.
    211. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nature Communications. 7.
    212. Cancer prevention in developing countries. Salud Publica de Mexico. 58:93-96.
    213. Foreword. Unknown Journal.
    214. Series Foreword. Unknown Journal. 9781118501627:ix-x.
    215. Cancer Prevention, Screening, and Early Detection. 322-359.
    216. Cancer Chemoprevention.
    217. Primary Hepatic Cancer. 161-181.
    218. The authors reply [9]. New England Journal of Medicine. 355:2371-2372.
    219. Designing the chemoprevention trials of tomorrow. 265-284.
    220. Chemoprevention in hereditary colorectal cancer syndromes. Cancer. 86:1731-1743.
    221. Development of breast cancer chemopreventive drugs. Breast Journal. 1:271-283.
    222. Colorectal Cancer Prevention and Aging. 85-96.
    223. Cancer Prevention Recommendations. Seminars in Oncology Nursing. 32:306-313.
    224. Handbook of Gastrointestinal Cancer.
    225. Germline genetic variants in the Wnt/β-catenin pathway as predictors of colorectal cancer risk. Cancer Epidemiology Biomarkers and Prevention. 25:540-546.
    226. Genomic landscape of colorectal mucosa and adenomas. Cancer Prevention Research. 9:417-427.
    227. Surrogate endpoint biomarker (SEB) guided drug development. Clinical Pharmacology and Therapeutics. 61:165.
    HAWK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (584)
    Explore
    _
    Co-Authors (140)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _